Stock analysis for Adverum Biotechnologies Inc (ADVM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ADVM / Adverum Biotechnologies, Inc. - Institutional ... Adverum Biotechnologies, Inc. (ADVM) Shares March Higher, Can It Continue? 2019-05-24 zacks.com - As of late, it has definitely been a great time to be an investor in Adverum Biotechnologies, Inc. (ADVM - Free Report) . The stock has moved higher by 38% in the … NASDAQ:ADVM Adverum Biotechnologies Earnings Date ... Earnings Adverum Biotechnologies (NASDAQ:ADVM) Earnings Information. Adverum Biotechnologies last issued its earnings data on May 28th, 2020. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.04.
(NASDAQ:ADVM)? View breaking news headlines for ADVM stock from trusted media outlets at MarketBeat. Share on Stocktwits. print this page. Print this Adverum Biotechnologies (NASDAQ:ADVM) Rating Lowered to Sell at Zacks Investment Research. Last updated on Thursday, June 11th, 2020 by MarketBeat . NLNK's SEC for stocks that are quantitatively similar to Zynerba Pharmaceuticals Inc, a group of peers worth examining would be BPMX, RVNC, ADVM, PSTI,
Adverum Biotechnologies, Inc. - ADVM - Stock Price Today ... View Adverum Biotechnologies Inc ADVM investment & stock information. Get the latest Adverum Biotechnologies Inc ADVM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Adverum Biotechnologies, Inc. - ADVM - Stock Price & News ... Adverum Biotechnologies, Inc. (ADVM) Q4 2019 Earnings Call Transcript Motley Fool Transcribers | Mar 13, 2020 ADVM earnings call for the period ending December 31, 2019. ADVM Interactive Stock Chart | Adverum Biotechnologies ...
Aldeyra Therapeutics. ALDX 4.86 0.03 (0.64%). NASDAQ Updated Jun 8, 2020 11:47 PM Amarin Corporation plc. AMRN 7.32 0.64 (9.57%). NASDAQ Updated Jun 8, 2020 8:01 PM Featured Post From StockTwits About ADVM $xnet short last year took $6k - this was China pump on bitcoin 🤣. This also came down but had to cover. ADVM closed up 11.84 percent on Friday, June 5, 2020, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought. Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 3:50 pm EDT.A live webcast will be accessible under Events and Presentations in the Investors section of the company s website. Adverum Biotechnologies Announces New INFINITY Phase 2 Trial for ADVM-022 in Diabetic Macular Edema, Reports Recent Business Progress and First Quarter 2020 Financial Results 05/28 16:01 Yahoo Adverum Biotechnologies Inc (NASDAQ:ADVM) issued its quarterly earnings results on Thursday, May, 28th. The biotechnology company reported ($0.31) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.27) by $0.04.
Adverum Biotechnologies, Inc. - ADVM - Stock Price & News ... Adverum Biotechnologies, Inc. (ADVM) Q4 2019 Earnings Call Transcript Motley Fool Transcribers | Mar 13, 2020 ADVM earnings call for the period ending December 31, 2019. ADVM Interactive Stock Chart | Adverum Biotechnologies ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ADVM | Stock Snapshot - Fidelity Jun 05, 2020